Regular sunscreen use roughly halved the risk of new melanoma over ten years of follow-up in the Nambour Skin Cancer Prevention Trial, a randomized trial of 1,621 Australian adults published by Green and colleagues in the Journal of Clinical Oncology in 2011. It is the strongest randomized evidence that sunscreen prevents skin cancer, and it clarifies what SPF (sun protection factor) does, and does not, promise on the label.
SPF measures how long sunscreen delays a burn
Sun protection factor is defined by a laboratory test. Sunscreen is applied at a standard thickness (2 milligrams per square centimeter of skin), the skin is exposed to a UV lamp, and the time to a mild sunburn is compared with the same skin exposed unprotected. If the sunscreen delays the burn by a factor of 30, its SPF is 30. Because UVB is the wavelength range that most directly causes sunburn (and is also a major driver of squamous cell and basal cell skin cancer), SPF is fundamentally a UVB measure.
The numbers behind SPF filtration are less linear than intuition suggests. SPF 30 blocks about 97% of UVB reaching the skin. SPF 50 blocks about 98%. SPF 100 blocks about 99%. The gains above SPF 50 are mathematically real but small in idealized conditions.
Real-world application undoes most of the difference
The laboratory test applies 2 milligrams per square centimeter. In real use, people typically apply between a quarter and a half of that. Under-application reduces the effective SPF steeply and non-linearly. A study by Faurschou and Wulf published in the British Journal of Dermatology in 2007 showed the relationship follows exponential decay, in which halving the applied amount reduces the effective SPF roughly to its square root, and using a quarter of the tested amount reduces it to its fourth root. In practical terms, an SPF 50 product applied at half the tested thickness delivers about SPF 7; applied at a quarter, closer to SPF 3. That is one of the practical arguments for using a higher-numbered product: it gives a buffer against the under-application that is nearly universal outside a testing laboratory.
SPF ignores UVA, which does its own damage
UVA radiation penetrates deeper into the skin than UVB and contributes independently to photoaging (wrinkles, loss of elasticity, pigment changes) and to DNA damage that raises skin cancer risk, including melanoma. SPF does not measure UVA protection. Products labeled “broad spectrum” have been tested against a standard that requires UVA protection roughly proportional to their UVB protection; the label is regulated in the United States by the FDA and in the European Union under different but similar criteria. A broad-spectrum SPF 30 applied properly is a better choice than a non-broad-spectrum SPF 100.
The Nambour trial is the clearest randomized evidence
In 1992, researchers randomly assigned 1,621 residents of Nambour, a town in Queensland, Australia, to either daily application of broad-spectrum SPF 16 sunscreen on the head, neck, arms, and hands, or continued discretionary use. Participants were followed until 2006, with melanoma incidence tracked through pathology laboratories and the Queensland cancer registry. Ten years after the intervention phase ended, the daily-sunscreen group had 11 new primary melanomas against 22 in the discretionary group, a hazard ratio of 0.50 (95% confidence interval 0.24 to 1.02). The reduction was larger for invasive melanoma: 3 cases in the sunscreen group versus 11 in controls, hazard ratio 0.27 (95% confidence interval 0.08 to 0.97). An earlier report from the same trial had already established that regular sunscreen use prevents cutaneous squamous cell carcinoma. The trial is small by contemporary standards but its randomized design and long follow-up make it the strongest single piece of evidence sunscreen prevention has produced.
Mineral and chemical filters both work
Sunscreens use two classes of active ingredients. Mineral (or physical) filters, principally zinc oxide and titanium dioxide, sit on the skin surface and reflect and scatter UV. Chemical (or organic) filters, including avobenzone, octinoxate, octisalate, and newer compounds, absorb UV and convert it to heat. Both provide effective protection when properly formulated and applied. Mineral filters are generally preferred for infants and for people with sensitive skin. Some chemical filters have raised safety questions about hormonal activity in laboratory studies, but the FDA has not concluded there is clinical harm at label doses, and the American Academy of Dermatology considers both classes safe for use.
The practical points do more than the choice of formulation
Sunscreen delivers only the protection that is actually applied. General guidance from dermatology societies: about a teaspoon for the face and neck, a shot glass (roughly 30 milliliters) for the whole body of an average adult, reapplied every two hours and after swimming or heavy sweating. Sunscreen works best combined with the other tools of sun protection: shade, hats, tightly woven clothing (some labeled with an ultraviolet protection factor, UPF), sunglasses, and avoiding direct sun during the highest-intensity hours (roughly 10 a.m. to 4 p.m., depending on latitude and season). Vitamin D concerns are usually addressed more reliably by diet or supplements than by deliberate sun exposure.
What the evidence cannot yet answer
The Nambour trial used SPF 16 in a light-skinned Australian population with high baseline sun exposure. Whether the same effect size applies at higher SPFs or in different populations is inferred rather than directly tested. Long-term systemic absorption of some chemical filters has been demonstrated in FDA-funded studies, but no clinical harm has been established at typical doses. And the balance between sunscreen use and vitamin D synthesis remains a genuine question for people with limited sun exposure or darker skin, where deficiency is more common.
References
- Green AC, Williams GM, Logan V, Strutton GM. Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up. Journal of Clinical Oncology, 2011; 29: 257-263. DOI: 10.1200/JCO.2010.28.7078
- Green A, Williams G, Neale R, et al. Daily sunscreen application and beta carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. The Lancet, 1999; 354: 723-729. DOI: 10.1016/S0140-6736(98)12168-2
- Faurschou A, Wulf HC. The relation between sun protection factor and amount of sunscreen applied in vivo. British Journal of Dermatology, 2007; 156: 716-719. DOI: 10.1111/j.1365-2133.2006.07684.x
- US Food and Drug Administration. Sunscreen: How to Help Protect Your Skin from the Sun. Available at: fda.gov
- American Academy of Dermatology. Sunscreen FAQs. Available at: aad.org